American International Group, Inc. Aldeyra Therapeutics, Inc. Transaction History

American International Group, Inc.

$8.5 Billion
Q3 2024

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 13, 2024	SELL	$2.77 - $4.22 $545 - $831	-197 Reduced 0.85%	22,952 $75,000
Q4 2023 Feb 13, 2024	SELL	$1.47 - $6.06 $138 - $569	-94 Reduced 0.4%	23,149 $81,000
Q3 2023 Nov 13, 2023	BUY	$6.11 - $8.16 $5,046 - $6,740	826 Added 3.68%	23,243 $155,000
Q2 2023 Aug 04, 2023	BUY	$7.11 - $11.89 $159,384 - $266,538	22,417 New	22,417 $188,000
Q2 2022 Aug 12, 2022	SELL	$2.43 - $4.85 $58,553 - $116,865	-24,096 Closed	0 $0
Q1 2022 May 13, 2022	SELL	$3.25 - $5.17 $5,512 - $8,768	-1,696 Reduced 6.58%	24,096 $107,000
Q4 2021 Feb 11, 2022	SELL	$3.5 - $9.63 $2,698 - $7,424	-771 Reduced 2.9%	25,792 $103,000
Q3 2021 Nov 12, 2021	SELL	$7.94 - $11.31 $5,018 - $7,147	-632 Reduced 2.32%	26,563 $233,000
Q2 2021 Aug 13, 2021	BUY	$10.44 - $14.85 $283,915 - $403,845	27,195 New	27,195 $308,000
Q2 2020 Aug 12, 2020	SELL	$1.97 - $5.05 $26,744 - $68,558	-13,576 Closed	0 $0
Q1 2020 May 04, 2020	SELL	$1.62 - $6.4 $1,270 - $5,017	-784 Reduced 5.46%	13,576 $34,000
Q4 2019 Feb 05, 2020	BUY	$4.73 - $7.98 $558 - $941	118 Added 0.83%	14,360 $83,000
Q3 2019 Nov 08, 2019	SELL	$4.41 - $6.12 $432 - $599	-98 Reduced 0.68%	14,242 $75,000
Q2 2019 Aug 13, 2019	BUY	$6.0 - $9.0 $5,208 - $7,812	868 Added 6.44%	14,340 $86,000
Q1 2019 May 06, 2019	SELL	$7.14 - $9.85 $3,120 - $4,304	-437 Reduced 3.14%	13,472 $122,000
Q4 2018 Feb 13, 2019	BUY	$7.26 - $13.29 $19,173 - $35,098	2,641 Added 23.44%	13,909 $115,000
Q3 2018 Nov 09, 2018	BUY	$6.8 - $14.35 $6,086 - $12,843	895 Added 8.63%	11,268 $155,000
Q2 2018 Aug 08, 2018	BUY	$6.95 - $9.18 $72,092 - $95,224	10,373 New	10,373 $82,000

Others Institutions Holding ALDX

# of Institutions

117

Shares Held

36.4M

Call Options Held

196K

Put Options Held

142K

Perceptive Advisors LLC New York, NY

9.28M
Shares

$44.4 Million
1.31% of portfolio
Knoll Capital Management, LLC Miami, FL

5.48M
Shares

$26.2 Million
14.56% of portfolio
Vanguard Group Inc Valley Forge, PA

3.76M
Shares

$18 Million
0.0% of portfolio
Black Rock Inc. New York, NY

3.62M
Shares

$17.3 Million
0.0% of portfolio
Kennedy Capital Management, Inc. St Louis, MO

1.88M
Shares

$9.01 Million
0.24% of portfolio

View Full List

About Aldeyra Therapeutics, Inc.

Ticker ALDX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 58,323,100
Market Cap $279M
Description
Aldeyra Therapeutics, Inc., a biotechnology company, develops and commercializes medicines for immune-mediated ocular and systemic diseases. The company's lead product candidate is reproxalap, a reactive aldehyde species (RASP)modulator, which is in Phase III clinical trial for the treatment of dry eye diseases and allergic conjunctivitis. It al...

More about ALDX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of American International Group, Inc., based on Form 13F filings with the SEC.

News

Stay updated on American International Group, Inc. with notifications on news.

Account